rxstatShortages › Fluocinonide

Fluocinonide shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Fluocinonide products are in shortage in Canada (2 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
2 / 10
In shortage since
Jan 1, 2014
Reports on file
47
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TOPACTIN CREAM 0.05% U.S.P.
0.05% · CREAM · PALADIN LABS INC
DIN 00816132 · since Jan 1, 2014, no end estimate · Other (Please describe in comments)
Active shortage
TOPACTIN EMOLLIENT CREAM 0.05%
0.5MG · CREAM · PALADIN LABS INC
DIN 02240269 · since Jan 1, 2014, no end estimate · Other (Please describe in comments)
Discontinued
LIDEX
0.05% · CREAM · BAUSCH HEALTH, CANADA INC.
DIN 02161923
Resolved
LYDERM CREAM 0.05%
0.05% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00716863 · ended May 5, 2023 · Disruption of the manufacture of the drug.
Resolved
LYDERM CREAM 0.05%
0.05% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00716863 · ended Jan 6, 2023 · Disruption of the manufacture of the drug.
Resolved
TIAMOL CREAM 0.05%
0.05% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00598933 · ended Nov 23, 2022 · Disruption of the manufacture of the drug.
Resolved
LYDERM CREAM 0.05%
0.05% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00716863 · ended Nov 15, 2022 · Disruption of the manufacture of the drug.
Resolved
LIDEMOL
0.05% · CREAM · BAUSCH HEALTH, CANADA INC.
DIN 02163152 · ended Jul 1, 2021 · Other (Please describe in comments)
Resolved
LIDEX
0.05% · GEL · BAUSCH HEALTH, CANADA INC.
DIN 02161974 · ended Jul 1, 2021 · Other (Please describe in comments)
Resolved
LYDERM CREAM 0.05%
0.05% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00716863 · ended Mar 4, 2021 · Disruption of the manufacture of the drug.
Resolved
LYDERM OINTMENT 0.05%
0.05% · OINTMENT · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 02236996 · ended Feb 15, 2021 · Disruption of the manufacture of the drug.
Resolved
LYDERM CREAM 0.05%
0.05% · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00716863 · ended Feb 10, 2021 · Disruption of the manufacture of the drug.

Showing 12 of 47 reports. All reports are on file with Health Canada.

What's happening

Fluocinonide is currently affected by 2 active shortage reports filed with Health Canada by PALADIN LABS INC.

The reported cause is: other (please describe in comments). Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Fluocinonide is classified under “CORTICOSTEROIDS, PLAIN” (ATC D07AC).

Recent changes

Common questions

When will Fluocinonide be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Fluocinonide in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (corticosteroids, plain)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.